Women and Lung Cancer Research and Preventive Services Act of 2019 (HR 2222, 116th Congress)

Policy Details

Policy Details

Originating Entity
Last Action
Referred to Committee
Date of Last Action
Apr 10 2019
Congressional Session
116th Congress
Date Introduced
Apr 10 2019
Publication Date
Apr 22 2019

SciPol Summary

The Women and Lung Cancer Research and Preventative Services Act of 2019 (HR 2222 / S 1107, 116th Congress) would commission a review — coordinated through the Department of Health and Human Services, Department of Veterans Affairs, and Department of Defense — to understand the current state of research on lung cancer in women, accessibility of services to prevent lung cancer, and public education materials on the topic of lung cancer. These departments would be tasked with developing a report on the current landscape, knowledge gaps, and opportunities to improve upon our knowledge of lung cancer in women. The Act then specifies that this report should highlight both environmental and genetic contributions to lung cancer in women.

A 2012 study emphasizes that lung cancer is different in females than males; in particular, females tend to be diagnosed at a younger age and develop different clinical presentations of the disease. Globally, lung cancer is the most prevalent type of cancer and, while rates of lung cancer have decreased since the early 200s, this decrease is occurring faster in males than in females.

For more information, see the Full Brief available for the Women and Lung Cancer Research and Preventative Services Act of 2018 (HR 4897 / S 2358, 116th Congress).

SciPol Summary authored by